Related references
Note: Only part of the references are listed.Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis
Ang Li et al.
THROMBOSIS RESEARCH (2019)
Genotype-guided warfarin dosing vs. conventional dosing strategies: a systematic review and meta-analysis of randomized controlled trials
Gary Tse et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Gary E. Raskob et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Anticoagulation Therapy in SELECTeD Cancer Patients at Risk of Recurrence of Venous Thromboembolism: Results of the 'select-d' Pilot Trial
A. Young et al.
THROMBOSIS RESEARCH (2018)
Treatment Outcomes of Cancer Associated Venous Thrombosis; The Cleveland Clinic Experience
D. E. Angelini et al.
THROMBOSIS RESEARCH (2018)
Anticoagulation for the Treatment of Cancer-Associated Thrombosis: A Systematic Review and Network Meta-Analysis of Randomized Trials
Diana M. Sobieraj et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2018)
Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: A network meta-analysis
Maria Cristina Vedovati et al.
THROMBOSIS RESEARCH (2018)
Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
Clive Kearon et al.
CHEST (2016)
RIVAROXABAN COMPARED TO LOW MOLECULAR WEIGHT HEPARIN IN TREATMENT OF MALIGNANCY ASSOCIATED VENOUS THROMBOEMBOLISM
Robert D. McBane et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer
Dominique Farge et al.
LANCET ONCOLOGY (2016)
Spotlight on advances in VTE management: CALLISTO and EINSTEIN CHOICE
Miriam Bach et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?
Alok A. Khorana et al.
THROMBOSIS RESEARCH (2016)
Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial
Gary E. Raskob et al.
LANCET HAEMATOLOGY (2016)
Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study
Walter Ageno et al.
LANCET HAEMATOLOGY (2016)
Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer A Randomized Clinical Trial
Agnes Y. Y. Lee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
S. Kaatz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial
G. Agnelli et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer
Sam Schulman et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials
Martin H. Prins et al.
LANCET HAEMATOLOGY (2014)
Parenteral anticoagulation in ambulatory patients with cancer
Elie A. Akl et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Epidemiology of cancer-associated venous thrombosis
Jasmijn F. Timp et al.
BLOOD (2013)
CANCER-ASSOCIATED THROMBOTIC DISEASE Treatment of cancer-associated thrombosis
Agnes Y. Y. Lee et al.
BLOOD (2013)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
P Prandoni et al.
BLOOD (2002)
Share Paper
